Osmium Partners, LLC 4
4 · Diversicare Healthcare Services, Inc. · Filed Sep 2, 2021
Insider Transaction Report
Form 4
Osmium Partners, LLC
10% Owner
Transactions
- Sale
Common Stock
2021-09-01$9.76/sh−49,900$487,119→ 454,733 total(indirect: By Osmium Capital, LP) - Sale
Common Stock
2021-09-01$9.76/sh−28,300$276,262→ 115,475 total(indirect: By Osmium Spartan LP) - Sale
Common Stock
2021-09-02$9.73/sh−60,000$583,518→ 394,733 total(indirect: By Osmium Capital, LP) - Sale
Common Stock
2021-09-02$9.73/sh−10,000$97,253→ 105,475 total(indirect: By Osmium Spartan LP) - Sale
Common Stock
2021-09-01$9.76/sh−21,800$212,809→ 185,136 total(indirect: By Osmium Capital II, LP) - Sale
Common Stock
2021-08-31$9.75/sh−40,000$390,120→ 504,633 total(indirect: By Osmium Capital, LP) - Sale
Common Stock
2021-08-31$9.75/sh−20,000$195,060→ 206,936 total(indirect: By Osmium Capital II, LP) - Sale
Common Stock
2021-08-31$9.75/sh−40,000$390,120→ 143,775 total(indirect: By Osmium Spartan LP) - Sale
Common Stock
2021-09-02$9.73/sh−30,000$291,759→ 155,136 total(indirect: By Osmium Capital II, LP)
Footnotes (1)
- [F1]The general partner of Osmium Capital, LP, Osmium Capital II, LP and Osmium Spartan, LP is Osmium Partners, LLC. John H. Lewis is the controlling member of Osmium Partners, LLC, and Mr. Lewis may be deemed to have voting and dispositive power with respect to the shares held by Osmium Capital, LP, Osmium Capital II, LP and Osmium Spartan, LP. Mr. Lewis disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Lewis is the beneficial owner of the shares for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.